A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine

Background: Cervical cancer is associated with persistent infection of high-risk human papillomaviruses (HPVs). Prophylactic HPV vaccines have been recommended and have significant efficacy in preventing cervical cancer. Multivalent HPV vaccines have a better preventative effect on HPV-related disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Xu, Jia-Dai Li, Jiao An, Xin-Xing Ma, Xiao-Liang Wang, Zheng Zhou, Hai-Ping Liu, Mei-Jun Diao, Yuan-Xiang Jiang, Ling-Yun Zhou, Xin Tong, Chen-Liang Zhou
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Vaccines
Subjects:
human papillomavirus (HPV)
virus-like particles (VLPs)
vaccines
immunogenicity
protective efficacy
Online Access:https://www.mdpi.com/2076-393X/12/12/1356
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/12/12/1356

Similar Items